Try our Advanced Search for more refined results
Life Sciences - April, 2017
343 articles
- Atty Deception Kills Pharma Whistleblower Suit, Judge Rules
- 10th Circ. Backs Law School Lecture Penalty For Okla. Atty
- Warning Would Have Kept Woman From J&J Talc, Jury Told
- 11th Circ. Backs Georgia 'Pill Mill' Doc's 20-Year Sentence
- Retrophin Waived Privilege Over Atty Docs, Shkreli Says
- 6 Cos. Price IPOs Totaling $1B To Conclude Flurry Of Deals
- Deals Rumor Mill: Paytm, M1, BASF
- Brand Battles: Google, Instagram, Bayer, 'Mad Men'
- 5 Firms Set To Launch May With 6 IPOs Surpassing $1.7B
- New Allergan Fat-Freezing Unit Hit With False Ad Suit
- Senators Revive Bill To Speed Up Generic Drug Approval
- Judge OKs Med Device Injury Claim Under Pa. Tort Law Ruling
- Taxation With Representation: Skadden, Wachtell, Allen
- Galena Biopharma Investor Claims Stock Votes Miscounted
- Why Medical Marijuana Delivery May Soon Be Legal In LA
- Health Hires: 8 Firms Add Health, Life Sciences Experts
- J&J Hit With $20M Pelvic Mesh Verdict In Philly
- Aventis Says K&L Gates Fee Bid Survives High Court Ruling
- The Mediator's Proposal As A Tool For Litigants
- FDA Approves Batten Disease Treatment Priced At $702K
- Investors Want Venture Funds Kept Out Of Theranos Suit
- Generic Drug Patent Cases Fell By One-Third In 2016: Report
- PE-Backed Retailer, UK Biotech Price IPOs Totaling $263M
- NuVasive Denied Stay Of Investor Suit Over Kickback Scheme
- Justices Struggle With BPCIA Enigma
- Co. Selling Adulterated Weight Loss Supplements, Buyers Say
- FDA Nominee Clears Senate Panel Despite Dems' Criticism
- Expectations After The Trump Administration's First 100 Days
- KBL Merger Files $100M IPO To Pursue Health Care Buy
- Boston Hospital Pays $10M To End Research Fraud Probe
- Texas Jury Hits GE For $44M Anesthesia Machine Monopoly
- Texas Sues FDA Over Ban On Import Of Execution Drug
- Medical Experts Call Zimmer MDL Subpoenas Inappropriate
- Amphastar Wants Momenta Drug Standards Info In Patent Suit
- South Korea Fines Novartis $48M Over Bribes To Doctors
- 2nd Circ. Reverses NYU's $3.5M Award In Drug License Spat
- Addressing Personal Jurisdiction Limits At The High Court
- UK Product Liability Law Moves Toward US Norms
- Fraudster In $172M Scheme Seeks A Light Sentence
- Bayer Fights En Banc Review Of Dow's $455M Patent Loss
- Pharmacies' Price-Fixing Actions Too Similar, Judge Says
- Propel Loses Quick Win Bids In Dental Device False Ad Row
- Lensar Secures Ch. 11 Plan OK, Lender Debt-To-Equity Deal
- Duke Can't Drop Whistleblower's False Research Data Suit
- Par Hit With Fees For 'Unsupported' Luitpold Patent Suit
- Feds, Ex-MLB Star Clash Over Insider Trading Jury Instructions
- Shkreli Lobs Password-Cracking Allegation At Retrophin
- Halt Medical Bid Protections Are Unnecessary, Trustee Says
- Thinking Fast And Slow About Class Action Reform
- 'Milking' The 1st Amendment To Defend Food Label Claims
- Allergan Settles Apotex Pinkeye Meds Product-Hopping Suit
- DNA Co. Beats Baby Gender Test Suit, For Now
- FINRA, DTC Want Suit Over Bankruptcy Distribution Killed
- Bankrupt Unilife Seeks $1M In Bonuses For Top Brass
- Justices Mull Biosimilar Duties At Amgen-Sandoz Arguments
- The 9-Year Winning Streak Of Virginia 'Rocket Docket'
- Jury Hits Cardio Device Maker With $25M Retaliation Verdict
- GSK Trial Shows Jury's New Role In Drug Labeling Cases
- FDA Warning Wire: Teva, Inspection Refusal, Cheese Deaths
- Medtox Fax Recipients Certified In Revived TCPA Suit
- Calif. Appeals Court Won't Revive Fosamax Suit
- Fed. Circ. Mostly Affirms PTAB In Duke Patent Dispute
- Ex-Hunton Atty Seeks Retrial After Insider Trading Conviction
- Oxygen Equipment Provider To Pay $11.4M To End FCA Suit
- Murder Trial For Pharmacist In Meningitis Outbreak Delayed
- Biotech Investors Seek Ruling On Jefferies Arbitration Fight
- Vagina Reshaping Patent Survives Invalidity Challenge
- Drug Co. Asks Justices To Limit Out-Of-State Tort Claims
- Merck Settles Keytruda Patent Suit For $19.5M
- Scott Gottlieb And The Future Of The FDA
- Let's Talk About Half-Hearted Innovation
- Merck Loses Rehearing Bid In 3rd Circ. Fosamax Warning Suit
- J&J's Talc Caused Woman's Cancer, Harvard MD Tells Jury
- Anthem, Express Scripts To Cut Ties Amid Pricing Fight
- Allen & Overy, Cravath Guide $4.3B Fresenius-Akorn Combo
- Pharmacy Says Aetna Owes $533K For Hemophilia Drugs
- Mylan Rebates Doomed EpiPen Rival, Sanofi Says
- Adderall Generic Blocked After Shire, Amerigen Settle
- 10 Tips For Creating Winning Trial Visuals
- 9th Circ. Says Class Can't Demand Proof In False Ad Row
- 5 Cos. Launch IPOs Surpassing $1.8B As Deals Accelerate
- Judge Keeps Fraud Claims Against GSK Alive In Zofran MDL
- Lilly Hit With $20M Jury Verdict In Cialis Patent Row
- Judge Says Clinics In Meningitis Outbreak Can Blame FDA
- Ex-Disney Workers' ERISA Suit Over Valeant Shares Gets Boot
- Deals Rumor Mill: Hypermarcas, Whole Foods, Abraaj Group
- Vitamin C Antitrust Case Could Trip Trump Up On Trade
- NuVasive Investors Slam Bid To Pause Kickback Class Action
- Test Maker Denies Eavesdropping On Abbott Suit Depos
- Plaintiffs Bar Perspective: Grant & Eisenhofer's Beth Graham
- Counsel To Counsel: Insights From Law Firm GCs
- Skadden, Wachtell Guide $24B Medical Supply Co. Deal
- Medtronic's $17M Patent Infringement Penalty Is Enhanced
- FDA Deluged With Feedback On Off-Label Policies
- No Doubt Talc Can Enter Body, Jury Told In J&J Cancer Trial
- Taxation With Representation: Skadden, Cravath, Simpson
- GSK's Paxil Loss Forces 7th Circ. Generic Liability Showdown
- More Details Out In Del. Bid To Stop Theranos Share Swap
- Meet The Attys Arguing Supreme Court Biosimilars Battle
- 5 Social Media Pitfalls In The Pharmaceutical Industry
- Pa. Mesh Cases Won't Be Stayed For Jurisdiction Appeals
- Honigman Miller Adds Ex-Kirkland & Ellis IP Atty In Chicago
- Tips For Finding Your Company's Hidden IP
- Gray Matters: The Attorney-Client Team
- Cherokees Say Wal-Mart, Walgreens Let Opioids Loose
- Stryker Cut From Zimmer's Howmedica Trade Secrets Suit
- Momenta, Sandoz Again Try To Nix Amphastar's Antitrust Suit
- FDA Warns That Kids Shouldn't Use Codeine, Tramadol
- Counsel To Counsel: Mama Said There'll Be Days Like This
- Walking The Lone Pine Trail
- Litigation Finance, Big Data And The Limits Of AI
- What Current Legal Developments Mean For Biosimilars
- Why Oregon Lawmakers Are Shielding Cannabis Buyers' Data
- Cornell, Illumina Settle Long-Running DNA Analysis IP Suit
- GSK Hit With $3M Verdict For Reed Smith Atty's Suicide
- Bayer Gets Quick Win In Suit Challenging Probiotic Claims
- Pfizer Hit With DOJ Subpoena Over Saline Shortages
- Diabetes Test Maker Eavesdropped In Abbott Suit, Attys Say
- Invisalign Patents To Get Yet Another Look At USPTO
- Indirect Share Purchasers Cleared To Sue Theranos
- Calif. Court Finds Plaintiff 'Vexatious' In GE Med Mal Suit
- 2nd Circ. Judge Rips NY Court's 'Crystal Clear Mistake'
- BioScrip Investors Lose Suit After Targeting Different Board
- Gilead's Unapproved Drug Plant Flouted FCA, 9th Circ. Told
- UK Biotech, Chinese Manufacturer Prime IPOs Totaling $82M
- What Companies Can Expect From The New FDA
- Shkreli, Ex-Katten Atty Get Fraud Trials Severed
- Fresenius, Dialysis Patients Spar Over Documents In MDL
- Female, Male Sexual Enhancement Supplements Recalled
- 4 Consumers Drop Abbott Depakote Birth Defect Suits
- Rutgers' BioArray Licensing Suit Kicked Back To State Court
- Is Multidistrict Litigation In Need Of Reform?
- Shire Files Infringement Suit On Same Day It Gets Drug Patent
- Plaintiffs Bar Perspective: Robbins Geller's Tor Gronborg
- An Earth Day Review Of 'Green Guide' False Advertising
- The ITC's Potential Role In Hatch-Waxman Litigation
- Why P&C Carriers Must Prepare For The Marijuana Market
- Counsel To Counsel: A Law Firm GC's Data Protection Duties
- SAC Capital Blasts Elan Investor's Award Bid In $135M Deal
- Ill. Pharmacy Hits Medical Supply Co. With TCPA Fax Suit
- 'Right To Try' Unapproved Drug Measure Passes Pa. House
- FDA Warning Wire: Faulty St. Jude Devices Used In Patients
- Czech Republic Presses DC Court To Nix $325M Award Suit
- Ariz. AG Gets $4.65M Settlement Over Theranos Blood Tests
- AstraZeneca Can't Shed FCA Suit Over Seroquel 'Scheme'
- Ex-MLB Player Says Limit Insider Trading Trial Instruction
- Medtronics Inks $6.1B Unit Sale To Cardinal Health
- NuVasive Seeks Stay In Investor Suit Amid Class Cert. Appeal
- Counsel To Counsel: Evaluating Positional Conflicts
- Divided Infringement After Eli Lilly V. Teva
- Applying Buckman Preemption To Antitrust And RICO Claims
- Widow's Trial Against GSK Wraps With $39M Damages Plea
- Calif. Says Boehringer Ingelheim Paid Barr $120M For Delay
- Theranos To Stay Out Of Lab Biz In Deal With CMS
- Miss. Sues Drug Cos. Over Medicaid Reimbursements
- Cravath Guides Ashland In $660M Pharmachem Deal
- NJ Tax Court Upholds $5M In Rite Aid Property Assessments
- 7 Cos. Launch IPOs Totaling $967M As Momentum Builds
- Pa. Judge Axes Latest Risperdal Breast-Growth Case Mid-Trial
- Toshiba Medical Settles MRI Patent Suit With NeuroGrafix
- Counsel To Counsel: 5 Challenges For A Law Firm GC
- Tracing The Path To Health Care Investigation Settlements
- Court Orders Document Production In Pharmacy Price Row
- Abbott Says Consumers Are Twisting Law In Depakote Suits
- Venable Cleared To Rep Supplement Co. In False Ad Suit
- SBA To Revise Small Biz Size Standards For Some Industries
- Drug Co. Investors Seek OK For Early $3.8M Settlement
- NECC Owner Says FDA Fraud Is 'Legal Impossibility'
- Biotech Investors Fortify Jefferies Arbitration Battle
- Riverside Collects $418M For Latest Investment Vehicle
- FDA Wants Answers From Abbott On St. Jude Device Security
- Teva Gets Quick Win In IUD Defect Suit
- Cordis Can't Bring Defect Suits To Fed. Court: 9th Circ.
- Chamberlain Hrdlicka Nabs Osha Liang IP Atty In Houston
- Lion Biotech Investors Sue Co. In Wake Of SEC Crackdown
- Ex-Marketing Head Hits Meda Pharmaceuticals With Bias Suit
- Drug Co. Hires Ex-SDNY Brass To Fight $181M Forfeiture
- Baxter Hit With DOJ Subpoena Over Saline Shortages
- Deals Rumor Mill: Toshiba, Verizon, Chiltern International
- Abbott, Alere Drop Court Battle For Smaller $5.3B Merger
- Judge Denies Quick Wins In Lannett CEO's Tax Penalty Suit
- Lawyers In Flow: Get Out Of Your Head And Into Your Case
- Taxation With Representation: Kirkland, Shearman, Davis
- Janssen, Bayer Lose Preemption Bids As Xarelto Trial Nears
- Patient Wants Atty Fee Nixed From DePuy Implant Settlement
- Judge Scolds Unilife DIP Lender For Unjustified Limits
- Berkeley Appeals PTAB Ruling In MIT, Broad CRISPR Dispute
- Judge Nixes Two Experts In NJ Accutane Litigation
- Halt Medical Gets DIP OK To Cover Payroll, Other Expenses
- False Ad Deal With Remedies Co. Gets Nod 2nd Time Around
- 4 Companies Price IPOs Totaling $668M To Cap Busy Week
- 3rd Circ. Will Decide Lipitor, Effexor Pay-For-Delay Suits
- Janssen, Bayer Call Xarelto MDL Exclusion Request Too Broad
- Purchasers Seek Namenda Litigation Docs In Antitrust Suit
- Pfizer Can't Shake Off-Label Marketing FCA Suit
- Halt Medical Files For Ch. 11 Amid Lawsuit Against Lenders
- Roxane Could Owe $2M After Patent Row Ruled 'Exceptional'
- 11th Circ. Denies Doc Stay To Appeal Libel Suit To Justices
- Fed. Circ. Tosses Patent Case Over Nobel-Winning Discovery
- Medical Device Maker Hits Rival With Trade Secrets Suit
- Fed. Circ. Upholds PTAB's Ax Of Novartis MS Drug Patent
- $454M Gown Verdict Says Jury Can Be Swayed Without Harm
- Jury Awards $12.2M To Surgery Tube Co. In False Ad Row
- Stakeholders Must Stay Aware Of E-Cigarette Science
- Spotlight On Corruption-Related Successor Liability Risks
- Generic Nucynta Officially Barred After Depomed Patent Win
- Allergan, Kissei Settle With Sandoz In Prostate Drug Suit
- Alere Escapes Lawsuit Alleging Blood-Testing Errors
- Boehringer Asks DC Circ. To Stay Aggrenox Doc Production
- Depakote Birth Defect Suits Lose Claims Over Repose Limit
- Medical Device E-Commerce Co. Faces TCPA Suit Over Faxes
- Shire Blasts Allergan's Discovery Bid In Antitrust Suit
- Tokai Shareholders File Suit To Stop Otic Pharma Deal
- Injectable Drug System Maker Unilife Hits Ch. 11 In Del.
- A Law Firm Ranking Model By 'Fake News & Distorted Reports'
- Plaintiffs Bar Perspective: Cohen Milstein's Betsy Miller
- Client Conflict Troubled Late Atty, Ex-Colleague Testifies
- J&J Hid Talc Cancer Risk For Profit, Jury Told
- Shire, Actavis Say Intuniv Settlement Not Reverse Payment
- FDA Warning Wire: Mylan's New Woes, NYC Juice Claims
- Guilty Drug Return Co. Should Forfeit $181M, Feds Say
- Bristol-Myers, Pfizer Sue To Halt Generic Blood Thinner
- HGH Supplement Co. Says False Ad Suit Lacks Evidence
- Natural Gas Co., Biotech Firm File IPOs Totaling $586M
- Pharmacist Seeks New Trial On Racketeering Conviction
- Vitamin Health's False Ad Fight Not Covered, 6th Circ. Says
- Metal In Brain Counts As Injury, Patients Tell 11th Circ.
- J&J, Bayer Seek 3rd-Party Funding Info In Pa. Xarelto Cases
- Liberty Tells 10th Circ. MusclePharm's $3M Claim Not Covered
- The 11th Circ.'s Unfortunate Do-Over Christiansen Verdict
- Bellwethers Chosen In 3M Warming Device Infection MDL
- Abbott Admitted To Depakote Mislabeling, Court Told
- Ex-Roche Worker Sues Insurer Over $1.6M Malpractice Ruling
- Roca Can't Unfreeze Assets To Pay Legal Fees, Judge Says
- Shire Scorches FTC Suit Over Anti-Generic Petitions
- Hi-Tech Wins Attys' Fees For ThermoLife 'Nuisance' IP Suit
- 5 Cos. Expand IPO Pipeline With New Filings Exceeding $400M
- Actavis, Taro, Teva Fixed Skin Steroid Price, Suit Says
- Aurobindo Fights To Lift Ban On Biopsy Dye In Mylan Row
- Pharmaceutical Co. Gets Quick Win in PCB Contamination Suit
- Kirkland Steers Bain, Cinven In $5.6B German Pharma Co. Buy
- Inside Trader Says SEC Wants Too-Harsh $2.2M Judgment
- Two IP Attorneys Join Armstrong Teasdale In Kansas City
- Boehringer, Sanofi Must Divest To Clear $24B Deal In Mexico
- Schiff Hardin In Chicago Gains Ex-Duane Morris IP Head
- J&J Unit Asks Judge To Toss Whistleblower's Retaliation Case
- Fed. Circ. Affirms Takeda Loss In Prevacid Patent Case
- 7th Circ. Won't Revisit Eyedrop Suit Against Merck, Others
- How New Expert Witness Rules May Impact Missouri Courts
- Jury Hits Kimberly-Clark, Halyard With $454M Fraud Verdict
- Theranos Investors Can't Delay Class Action-Ending Deal
- 5 Firms To Steer IPOs Totaling $782M As Deals Gather Steam
- Shkreli, Ex-Katten Atty Warn Of Joint Trial Disarray
- JPML Sends Generic Drug Price-Fixing Suits To Pennsylvania
- GlaxoSmithKline Asks Justices To Rule On Paxil Jurisdiction
- Amneal Infringed Truvada Patents, Gilead Says
- Bellwether Trial Dates Set In Meningitis MDL
- Teva, Others Must Face Blood Pressure Drug Antitrust Suit
- Health Hires: Vt. SG To Stris, BCBS In-House To Kilpatrick
- Investors Sue AbbVie Over $1.6B Fee, Say More Loss Looms
- New Strategies For Licensing Of Multicomponent Inventions
- Crowdfunding For Legal Cases: 5 Trends Reshaping Justice
- Gov't Fights Over Facts In Ex-MLB Insider Trading Trial
- Chinese Investor Drops $1.4B For German Drugmaker
- McDermott Nabs Litigation Partner In Dallas From DLA Piper
- Supplement Co. Says Science Backs Up Its Memory Booster
- GSK Doc Says FDA Knew All Co. Did About Paxil Suicide Risk
- Celebrex Buyers Seek Class Cert. In Pfizer Antitrust Suit
- Mylan, Sandoz, Taro Accused Of Fixing OCD Drug Price
- Special Master Appointed In Depakote Trial
- Merck Wants 3rd Circ. Rethink On Fosamax Warning Claims
- Fed. Circ. Rules Mylan Doesn't Infringe Angiomax Patents
- Supplement Co. Fired Staff Over Lawsuit Fears: NLRB Judge
- Ill. City Latest To Sue Mallinckrodt In Antitrust Row
- Amphastar, Momenta Antitrust Dispute Gets 2019 Trial Date
- FDA Backs 23andMe Tests For Parkinson's, Alzheimer's Risks
- Drugmakers Face Antitrust Class Action Over Diabetes Drug
- Investor Suits Against Teva Combined, Moved To Conn.
- Agreement Via Email To End IP Row Is Valid, Judge Says
- ABA Needs A New Model Legal Ethics Rule
- What Does Lateral Partner Success Look Like?
- Kimberly-Clark Gown Buyers Didn't Pay A Premium, Jury Told
- Over FTC Protest, Lidoderm Pay-For-Delay Suit Stayed
- Gorsuch, Roe And 'Superprecedent'
- 5 Takeaways As Trump's FDA Pick Hits Capitol Hill
- Ex-MLB Player Seeks Acquittal On Insider Trading Charges
- Sanofi To Pay $19.8M To Settle VA's Overcharge Claims
- Alere Presses Del. Court For Access To Abbott Atty Docs
- Venable Gets Digital Health, Privacy Pro From Cooley
- Walgreens Hit With False Ad, IP Suit Over Eyelid Scrub
- Medical Co. Founder's Widow Accuses NJ Atty Of Malpractice
- Medtronic Says Some Ventilators Can Reset Without Warning
- Are Lateral Recruitment Opportunities Shaping Your Strategy?
- 2 Plead Not Guilty In Pharmaceutical Insider Trading Scheme
- Xtant Shareholder Demands Books And Records
- J&J, Mesh Patient End Texas High Court Appeal
- The Trump Administration's Views On Marijuana Enforcement
- Devil Is In The Detail: Lessons On Drafting Earnouts
- Sandoz, Lupin To Pay Combined $6.7M In Pay-For-Delay MDL
- NJ Pharma Co. Hits Manufacturer With €3M Commissions Suit
- Xencor Recap Settlement's $2.4M Balance Approved In Del.
- Express Scripts Concealing Basic Pricing Info, Anthem Says
- Fed. Circ. Backs $6M Fee Award For Medtronic In Patent Case
- FDA Warning Wire: Agency Skeptical Of Cannabis Oil Claims
- Vitamin C Buyers Ask Supreme Court To Revive Antitrust Suit
- Biogen Accused Of Stifling Neurological Drug Competition
- Lateral Partner Hiring: Time To Look In The Mirror
- Swiss-American Must Face False Sunscreen SPF Class Action
- GSK Can't Score Early Win In Atty Suicide Trial
- Gov't Says Ex-MLBer Can't Admit 'Sloppy' Notes In Trial
- Pa. Appeals Court Won't Revive Liquisolid Licensing Row
- KKR-Backed REIT, British Biotech Join Growing IPO Pipeline
- Fed. Circ. Affirms Nix Of Novartis Dementia Patch Patents
- Ex-NFLer Fights SEC's Negligence Verdict At 9th Circ.
- McKesson Investor Sues Board After $150M DOJ Fine
- Mintz Levin Nabs Ex-Kilpatrick Townsend Patent Partner
- Investors Push For FINRA Arbitration In Battle With Jefferies
- Biotech CEO Dodges Prison For False SEC Filings
- Printing Co. CEO Admits To Trafficking Fake Vet Med Labels
- Kimberly-Clark Gowns Should Have Been Recalled, Jury Told
- 6 More Sentenced In Fla. For $172M Insurance Fraud
- Fla. Senate Panel Expands Medical Marijuana Bill
- Atty Wasn't Driven To Suicide By Work: Reed Smith Partner
- Allergan Must Face FCA Suit Over Drug Samples, Rx Pads
- PTAB Invalidates Patent For Hypertension Treatment
- FCA Decision Tracker: Continued Interpretations Of Escobar
- Patients Ask 5th Circ. To Restore $502M J&J Hip Verdict
- Krill Oil Cos. Reach $1.6M Deal To End Patent Dispute
- BCBS Gets Heart Device Co.'s $66.5M Antitrust Suit Tossed
- Dow Wants Review Of $455M Weed Control Patent Loss
- New Philly Jury Begins 7th Risperdal Trial
- NY Goes After MedImmune In Kickback Scheme Suit
- Recall Of Potentially Faulty EpiPens Widens
- Impax, AstraZeneca Get Win In Generic Zomig Patent Case
- PE-Backed Met Coal Co. Leads 3 IPO Launches Totaling $530M
- Novartis' Hep C Patents Invalid Under Alice, AbbVie Says
- PTAB Allows Shire To Amend Adderall Patent In AIA Review
- Justices Won't Hear Reglan Failure-To-Warn Appeal
- 6 Cos. Expand Growing IPO Pipeline With New Filings
- Enzymotec Settles IPO Stock-Drop Suit For $6.5M
- Tibet Pharmaceuticals Exec Escapes Class Action Over IPO
- Four Firms Guide Apax Partners' $397M Deal For Syneron
- Another Step Toward Reasonable Preemption Case Law